3 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 1 | Terminated 1 |
Follow Anetoderma: new trials by email Literature Review of Anetoderma trials Research Report on Anetoderma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 GT005 - Dry Age-related Macular Degeneration | Phase 2 | Terminated | Gyroscope Therapeutics Limited | 255 | 2020-09-28 | 2026-01-28 |
| EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 GT005 - Dry Age-related Macular Degeneration | Phase 2 | Terminated | Gyroscope Therapeutics Limited | 98 | 2019-04-26 | 2026-01-27 |
| FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD GT005, GT005 / Device: Orbit™ Subretinal Delivery System - Dry Age-related Macular Degeneration, Macular Degeneration | Phase 1 / Phase 2 | Terminated | Gyroscope Therapeutics Limited | 56 | 2018-12-17 | 2026-01-28 |
Eye Diseases (3) · Geographic Atrophy (3) · Retinal Degeneration (3) · Retinal Diseases (3) · Macular Degeneration (1)
Connective Tissue Diseases (3) · Eye Diseases, Hereditary (3) · Skin Abnormalities (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Macular Degeneration (2)
Gyroscope Therapeutics Limited (3)
United Kingdom (3) · United States (3) · Australia (2) · France (2) · Germany (2) · Poland (2) · Spain (2) · Netherlands (1)
2019 (1)